Resource Center
In this episode of the Eurofins Viracor podcast, our strategic brand manager, Kevin Foth hosts an in-depth discussion with Eurofins Viracor President, Michelle Altrich, and Chief Scientific Officer, Steve Kleiboeker as they delve into the company's 40-year history. They share insights into the company’s founding, our evolution in the diagnostics landscape, the challenges we’ve overcome, the pivotal moments that have defined our path in the field of diagnostics, and the innovative spirit that drives our commitment to precision medicine. Listeners will gain a deeper understanding of the milestones that have shaped the organization and our ongoing goal to advance patient care through cutting-edge technology.
This bi-lateral lung transplant recipient is a 65 year-old male patient who received his lung transplant due to end-stage lung disease secondary to non-CF bronchiectasis. The donor and recipient CMV serostatus is D+/R+. The patient’s initial peri-operative course was complicated by difficult explant, primary graft dysfunction, respiratory failure requiring prolonged mechanical ventilation, renal insufficiency and recurrent infectious concerns, including pseudomonas and stenotrophomonas pneumonias.